Table 2.
Baseline characteristics of people who continue and stop inhaled corticosteroids.
| Non-stoppers | Stoppers | |
|---|---|---|
| N (%) | N (%) | |
| Denominator | 708 | 219 |
| Age at baseline (SD) | 68.2 (11.8) | 69.1 (12) |
| <60 years | 169 (23.9) | 47 (21.5) |
| ≥60 years | 539 (76.1) | 172 (78.5) |
| Gender | ||
| Male | 422 (59.6) | 141 (64.4) |
| Female | 286 (40.4) | 78 (35.6) |
| Ethnic Group | ||
| White | 513 (72.5) | 142 (64.8) |
| South Asian | 148 (20.9) | 62 (28.3) |
| Black | 18 (2.5) | 7 (3.2) |
| Other/unknown | 29 (4.1) | 8 (3.7) |
| Deprivation quintile | ||
| 1 (least deprived) | 142 (20.1) | 44 (20.2) |
| 2 | 142 (20.1) | 44 (20.2) |
| 3 | 136 (19.2) | 47 (21.6) |
| 4 | 151 (21.4) | 41 (18.8) |
| 5 (most deprived) | 136 (19.2) | 42 (19.3) |
| Smoking Status | ||
| Current non-smoker | 405 (57.7) | 140 (64.2) |
| Current smoker | 297 (42.3) | 78 (35.8) |
| Baseline comorbidities | ||
| Atrial fibrillation | 50 (7.1) | 24 (11) |
| Cancer | 70 (9.9) | 22 (10) |
| CHD | 146 (20.6) | 54 (24.7) |
| CKD | 131 (18.5) | 44 (20.1) |
| Dementia | 16 (2.3) | 6 (2.7) |
| Depression | 192 (27.1) | 54 (24.7) |
| Diabetes | 182 (25.7) | 64 (29.2) |
| Epilepsy | 13 (1.8) | 4 (1.8) |
| Heart failure | 42 (5.9) | 25 (11.4) |
| Hypertension | 341 (48.2) | 106 (48.4) |
| Osteoporosis | 46 (6.5) | 12 (5.5) |
| Peripheral arterial disease | 46 (6.5) | 6 (2.7) |
| Rheumatoid arthritis | 18 (2.5) | 9 (4.1) |
| Serious mental illness | 21 (3) | 9 (4.1) |
| Stroke | 48 (6.8) | 16 (7.3) |
aBaseline is date of first ICS prescription during post-intervention period.